Insider Title Company Date Price Return Shares Value
Frankenius Equity Ab Non-Executive TriSalus Life Sciences, Inc. (TLSI) 2024-12-17 $3.97 0.0% 62,972 $249,999
Return Profit / (loss) Cost
Total 0.0% $0 $249,999